TSE:6099Healthcare
Elan (TSE:6099) Earnings Growth Outpaces 12.4% Revenue Run Rate And Tests Valuation Skeptics
Elan (TSE:6099) has wrapped up FY 2025 with fourth quarter revenue of ¥14.7b and basic EPS of ¥12.31, while trailing twelve month figures sit at ¥55.4b in revenue and EPS of ¥45.75, giving investors a clear view of the current earnings run rate. The company has seen quarterly revenue move from ¥12.0b in FY 2024 Q3 to ¥14.7b in FY 2025 Q4, with basic EPS over those reported quarters ranging from ¥8.39 to ¥13.23, setting the backdrop for its FY 2025 earnings discussion. With trailing net profit...